insights_auto
Kwa nini INO imepungua kwa 2.10%?
Fahamu zaidichevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$Â 1.40
arrow_downward
-2.10%(-0.030) Siku 1
16 Nov, 14:10:35 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya INO...
Fungua
US$Â 1.42
Juu
US$Â 1.48
Chini
US$Â 1.37
Mtaji wa soko
262.23M
Wastani wa kiasi cha mauzo
19.34M
Kiasi cha mauzo ya hisa
4.14M
Juu kwa wiki 52
US$Â 2.72
Chini kwa wiki 52
US$Â 0.57
EPS
-US$Â 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Fungua
US$Â 1.42
Juu
US$Â 1.48
Chini
US$Â 1.37
Mtaji wa soko
262.23M
Wastani wa kiasi cha mauzo
19.34M
Kiasi cha mauzo ya hisa
4.14M
Juu kwa wiki 52
US$Â 2.72
Chini kwa wiki 52
US$Â 0.57
EPS
-US$Â 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Korea Times
·
saa 1 iliyopita
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
saa 1 iliyopita
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
saa 2 zilizopita
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
The Motley Fool
·
dakika 41 zilizopita
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Wasifu
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Kuhusu Inovio Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Jacqueline Shea
Wafanyakazi112
Lilianzishwa1999
Makao makuu-
SektaHealth Care
Sekta-
Tovutiinovio.com